This product is a recombinant antibody that recognizes IL13. The monoclonal antibody mAb13.2 reacts with the epitope of IL13. Fully Humanized mAb13.2 Neutralizes IL-13-Associated Activities In Vitro.
Figure 1 Cynomolgus monkey IL-13 has bioactivity and can be neutralized with antibodies.
A half-maximal concentration of human (open symbols) or NHP (solid symbols) IL-13 was combined with the indicated concentration of mAb13.2.
Figure 2 Anti–IL-13 antibody reduced total BAL inflammation in response to A suum challenge.
Animals were given IVIG or saline (control), dexamethasone (DEX), or anti–IL-13 (mAb13.2 or IMA-638). Total cells.
Bree, A., Schlerman, F. J., Wadanoli, M., Tchistiakova, L., Marquette, K., Tan, X. Y., ... & Vunnum, S. (2007). IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. Journal of Allergy and Clinical Immunology, 119(5), 1251-1257.
Figure 3 Anti–IL-13 antibody reduced total BAL inflammation in response to A suum challenge.
Animals were given IVIG or saline (control), dexamethasone (DEX), or anti–IL-13 (mAb13.2 or IMA-638). Neutrophils.
Bree, A., Schlerman, F. J., Wadanoli, M., Tchistiakova, L., Marquette, K., Tan, X. Y., ... & Vunnum, S. (2007). IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. Journal of Allergy and Clinical Immunology, 119(5), 1251-1257.
Figure 4 Serum concentration of anti–IL-13 Ab in human doseranging studies.
Serum concentrations of IMA-638 or IMA-026 were determined by ELISA.
Kasaian, M. T., Raible, D., Marquette, K., Cook, T. A., Zhou, S., Tan, X. Y., & Tchistiakova, L. (2011). IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2. The Journal of Immunology, 187(1), 561-569.
Figure 5 Anti–IL-13 Abs differentially affect IL-13 internalization.
Assays were developed to detect IL-13 in the presence or absence of anti-IL-13 Abs: IMA-026. The extracellular medium was collected and assayed for IL-13 using ELISAs developed to detect the cytokine in the presence of anti–IL-13 Ab.
Kasaian, M. T., Raible, D., Marquette, K., Cook, T. A., Zhou, S., Tan, X. Y., & Tchistiakova, L. (2011). IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2. The Journal of Immunology, 187(1), 561-569.
Figure 6 Surface plasmon resonance (Biacore) analysis of human or sheep IL-13 binding to immobilized sIL-13R or IMA-638.
Human IL-13 binding to IMA-638.
Kasaian, M. T., Donaldson, D. D., Tchistiakova, L., Marquette, K., Tan, X. Y., Ahmed, A., ... & Barry, A. B. (2007). Efficacy of IL-13 neutralization in a sheep model of experimental asthma. American journal of respiratory cell and molecular biology, 36(3), 368-376.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1287z | Mouse Anti-IL13 Recombinant Antibody (clone 39B4) | WB, IP, IF, ELISA | Mouse IgG1, κ |
PABL-232 | Human Anti-IL13 Recombinant Antibody (clone M1295) | WB, IHC, FuncS | Human IgG |
MOB-0781CT | Recombinant Mouse anti-Human IL13 Monoclonal antibody (43227.22) | ELISA, Neut, WB | |
FN-135CQ | Rat Anti-IL13 Recombinant Antibody (clone JES10-5A2.2) | ELISA, FC, IHC, Neut, WB | Rat IgG1 |
HPAB-0355-WJ | Human Anti-IL13 Recombinant Antibody (clone 13C5.5) | ELISA, Neut, FuncS | Humanized IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-219 | Anti-Human IL13 Recombinant Antibody (Lebrikizumab) | ELISA, Neut, IF, IP, FC, FuncS | IgG4 - kappa |
TAB-395CL | Human Anti-IL13 Recombinant Antibody (TAB-395CL) | FuncS | Human IgG |
TAB-043ZJ | Anti-Human IL-13 Recombinant Antibody (Lc6Hc2) | ELISA | Humanized antibody |
TAB-044ZJ | Human Anti-IL13 Recombinant Antibody (TAB-044ZJ) | ELISA, Neut | Humanized IgG |
TAB-045ZJ | Human Anti-IL13 Recombinant Antibody (TAB-045ZJ) | ELISA, Block | Humanized IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-598 | Human Anti-IL13 Recombinant Antibody (clone C836); Fab Fragment | Neut | Chimeric (mouse/human) Fab |
PFBL-600 | Human Anti-IL13 Recombinant Antibody (clone H2L6); Fab Fragment | ELISA | Humanized Fab |
PFBL-601 | Human Anti-IL13 Recombinant Antibody (clone X836); Fab Fragment | WB, ELISA, FuncS | Chimeric (mouse/human) Fab |
PFBW-170 | Human Anti-IL13 Recombinant Antibody (clone CNTO607); Fab Fragment | ELISA, WB, Neut | Human Fab |
HPAB-0045LY-F(E) | Human Anti-IL13 Recombinant Antibody (clone IMA-026); Fab Fragment | WB | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-022ZJ | Anti-Human IL-13 Recombinant Antibody (C836) | ELISA | |
TAB-023ZJ | Mouse Anti-IL13 Recombinant Antibody (TAB-023ZJ) | ELISA, Block | Mouse IgG |
TAB-022ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (C836) | ELISA | |
TAB-023ZJ-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-023ZJ-S(P)) | ELISA, Block | Mouse scFv |
TAB-022ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (C836) | ELISA |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-094ZJ | Anti-Human IL-13 Recombinant Antibody (167) | ELISA | Chimeric antibody (mouse/human) |
TAB-094ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (167) | ELISA | Chimeric antibody (mouse/human) |
TAB-094ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (167) | ELISA | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-067ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (CNTO 607) | ELISA, Inhib | Human antibody |
TAB-067ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (CNTO 607) | ELISA, Inhib | Human antibody |
TAB-068ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (01471/G6) | ELISA, Neut | Human antibody |
TAB-069ZJ-F(E) | Human Anti-IL13 Recombinant Antibody; Fab Fragment (TAB-069ZJ-F(E)) | ELISA, Neut, FC | Human Fab |
TAB-070ZJ-F(E) | Human Anti-IL13 Recombinant Antibody; Fab Fragment (TAB-070ZJ-F(E)) | ELISA, Neut, FC | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1171CQ | Mouse Anti-IL13 Recombinant Antibody (clone B-B13) | ELISA, ELISPOT, Neut | Mouse IgG1 |
NEUT-1172CQ | Mouse Anti-IL13 Recombinant Antibody (clone 10X28) | Neut, WB | Mouse IgG1 |
NEUT-1173CQ | Mouse Anti-IL13 Recombinant Antibody (clone 15H10) | Neut | Mouse IgG2b |
NEUT-1174CQ | Mouse Anti-IL13 Recombinant Antibody (clone 32116.11) | ELISA, Neut, WB | Mouse IgG1 |
NEUT-1189CQ | Rat Anti-Il13 Recombinant Antibody (clone 1316H) | FuncS, Neut | Rat IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1790 | Rabbit Anti-IL13 Recombinant Antibody (clone DS1790AB) | WB, ICC, FC, IP | Rabbit IgG |
MOR-4610 | Rabbit Anti-IL13 Recombinant Antibody (clone TH123DS) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-H05 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Anrukinzumab), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | ADCC enhanced antibody |
AFC-TAB-017ML | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Dectrekumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, Inhib | ADCC enhanced antibody |
AFC-TAB-219 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Lebrikizumab), ADCC Enhanced | ELISA, Neut, IF, IP, FC, FuncS | ADCC enhanced antibody |
AFC-TAB-218 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Tralokinumab), ADCC Enhanced | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1739-FY-F(E) | Mouse Anti-IL13 Recombinant Antibody (clone mAb13.2); scFv Fragment | Inhib, ELISA | Mouse scFv |
HPAB-1740-FY-F(E) | Mouse Anti-IL13 Recombinant Antibody (clone ch13.2); scFv Fragment | Inhib, ELISA | Mouse scFv |
HPAB-1741-FY-F(E) | Human Anti-IL13 Recombinant Antibody (clone h13.2v1); scFv Fragment | Inhib, ELISA | Humanized scFv |
HPAB-1742-FY-F(E) | Human Anti-IL13 Recombinant Antibody (clone V2.11); scFv Fragment | ELISA, Inhib | Human scFv |
HPAB-1743-FY-F(E) | Human Anti-IL13 Recombinant Antibody (clone 01471/G6); scFv Fragment | ELISA | Human scFv |
There are currently no Customer reviews or questions for HPAB-1739-FY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.